138 related articles for article (PubMed ID: 6219736)
1. Cytostatic activity on tumour cells of monocytes from patients with gastrointestinal cancer.
Mytar B; Zembala M; Uracz W; Czupryna A
Cancer Immunol Immunother; 1982; 13(3):190-3. PubMed ID: 6219736
[TBL] [Abstract][Full Text] [Related]
2. "Activated" monocytes in gastric cancer patients. II. Suppressor and cytostatic activity in vitro.
Uracz W; Mytar B; Zembala M; Ruggiero I; Popiela T; Czupryna A
J Cancer Res Clin Oncol; 1982; 104(3):307-13. PubMed ID: 6219114
[TBL] [Abstract][Full Text] [Related]
3. Dissociation between tumour cell cytostatic and immuno-suppressive capacity of human monocytes activated with lymphokines.
Unsgaard G; Hammerstrøm J; Lamvik J
Acta Pathol Microbiol Immunol Scand C; 1982 Apr; 90(2):73-9. PubMed ID: 7080839
[TBL] [Abstract][Full Text] [Related]
4. Regulation of human lymphocyte response in vitro by monocytes and their subsets.
Zembala M; Pryjma J; Uracz W; Kowalczyk D; Ruggiero I; Mytar B
Folia Biol (Praha); 1986; 32(1):1-11. PubMed ID: 2938988
[TBL] [Abstract][Full Text] [Related]
5. Monocyte changes in cancer patients and their role in mitogen induced lymphocyte responses.
Uracz W; Pituch A; Mytar B; Noworolski J; Zembala M
Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):429-34. PubMed ID: 312077
[TBL] [Abstract][Full Text] [Related]
6. Human adherent mononuclear blood cells: cytolytic and cytostatic activity and characterization of effector cells during in vitro culture.
Hammerstrøm J
Acta Pathol Microbiol Scand C; 1981 Apr; 89(2):115-22. PubMed ID: 7293779
[TBL] [Abstract][Full Text] [Related]
7. Strong suppression by monocytes of T cell mitogenesis in chicken peripheral blood leukocytes.
Schaefer AE; Scafuri AR; Fredericksen TL; Gilmour DG
J Immunol; 1985 Sep; 135(3):1652-60. PubMed ID: 3160775
[TBL] [Abstract][Full Text] [Related]
8. Supressor monocytes in patients with systemic lupus erythematosus. Evidence of suppressor activity associated with a cell-free soluble product of monocytes.
Markenson JA; Lockshin MD; Fuzesi L; Warburg M; Joachim C; Morgan JW
J Lab Clin Med; 1980 Jan; 95(1):40-8. PubMed ID: 6444233
[TBL] [Abstract][Full Text] [Related]
9. Direct effects of Corynebacterium parvum and BCG on human monocyte-mediated tumour cell cytostasis in vitro.
Hammerstrøm J
Acta Pathol Microbiol Scand C; 1979 Aug; 87C(4):293-300. PubMed ID: 386712
[TBL] [Abstract][Full Text] [Related]
10. Expansion of autorecognitive cytotoxic effectors in human cancer by T cell growth factor (Interleukin 2)1.
Vose BM
Arch Geschwulstforsch; 1981; 51(4):317-26. PubMed ID: 6459065
[TBL] [Abstract][Full Text] [Related]
11. Comparative analysis of monocytic and granulocytic myeloid-derived suppressor cell subsets in patients with gastrointestinal malignancies.
Duffy A; Zhao F; Haile L; Gamrekelashvili J; Fioravanti S; Ma C; Kapanadze T; Compton K; Figg WD; Greten TF
Cancer Immunol Immunother; 2013 Feb; 62(2):299-307. PubMed ID: 23011590
[TBL] [Abstract][Full Text] [Related]
12. Depressed T lymphocyte function in brain tumor patients: monocytes as suppressor cells.
Wood GW; Morantz RA
J Neurooncol; 1983; 1(2):87-94. PubMed ID: 6236289
[TBL] [Abstract][Full Text] [Related]
13. Immunoregulatory abnormalities in chronic lymphocytic leukemia. I. Correlations of immunoregulatory subpopulations with stage of disease.
Keller RH; Blake DG; Lyman S; Siebenlist R
J Clin Lab Immunol; 1981 Nov; 6(3):201-9. PubMed ID: 6461766
[TBL] [Abstract][Full Text] [Related]
14. Suppression of monocyte mediated anti U562 cytotoxicity by soluble factors in the serum of cancer patients and in the supernatant of K562 cell culture.
Kiczka W; Szkaradkiewicz A
Immunol Lett; 1986 Sep; 13(3):127-31. PubMed ID: 3744433
[TBL] [Abstract][Full Text] [Related]
15. Generation of suppressor cells for natural killer activity in cancer patients after surgery.
Uchida A; Kolb R; Micksche M
J Natl Cancer Inst; 1982 May; 68(5):735-41. PubMed ID: 6461792
[TBL] [Abstract][Full Text] [Related]
16. Cytostatic effect on tumour cells induced in human monocytes by mediators from BCG-stimulated lymphocytes and MLC.
Unsgaard G; Hammerström J; Lamvik J
Acta Pathol Microbiol Scand C; 1979 Jun; 87C(3):159-66. PubMed ID: 158283
[TBL] [Abstract][Full Text] [Related]
17. [Immunologic studies on the patients with gastrointestinal cancer--with particular reference to correlation between T lymphocyte and macrophage].
Fujimoto S; Ishigami H; Kitsukawa Y; Amemiya K; Ohyama Y; Kure M; Endoh F; Okui K
Gan To Kagaku Ryoho; 1982 Mar; 9(3):534-9. PubMed ID: 6985192
[TBL] [Abstract][Full Text] [Related]
18. [Elimination of suppressor macrophages in tumor-bearing mice by 6-mercaptopurine and its therapeutic contribution].
Kataoka T
Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 2):701-5. PubMed ID: 3963841
[TBL] [Abstract][Full Text] [Related]
19. Effects of a prospective antitumor agent, 1,4-bis(2'-chloroethyl)-1,4-diazabicyclo-[2.2.1] heptane diperchlorate, on cultured mammalian cells.
Traganos F; Darzynkiewicz Z; Bueti C; Melamed MR
Cancer Invest; 1984; 2(1):1-13. PubMed ID: 6584191
[TBL] [Abstract][Full Text] [Related]
20. Nonspecific human lymphocyte-mediated cytotoxicity induced by immobilized IgG aggregate: regulation by suppressor cells.
Fuson EW; Sugantharaj DG; Hubbard RA
J Clin Lab Immunol; 1982 Jan; 7(1):55-60. PubMed ID: 6461768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
